Drugs.com
FEBRUARY 20, 2025
THURSDAY, Feb. 20, 2025 -- Social media often tempts teenagers with non-surgical ways to improve their appearance, such as laser hair removal, skin and teeth whitening, chemical peels, botox, and face and lip fillers.And a new poll finds that a.
Science Daily: Pharmacology News
FEBRUARY 21, 2025
Researchers have applied a visualization technique to depict the brain's activity related to visual perception as geometric patterns. They visualized different shapes as the ever-changing neuronal activity in the temporal and frontal lobes of the brain during object recognition and recalling memories. This achievement promises further extraction of brain activity observed in various aspects of daily life.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Covalent Modifiers
FEBRUARY 21, 2025
Teresa Marker, Raphael R. Steimbach, Cecilia Perez-Borrajero, Marcin Luzarowski, Eric Hartmann, Sibylle Schleich, Daniel Pastor-Flores, Elisa Espinet, Andreas Trumpp, Aurelio A. Teleman, Frauke Grter, Bernd Simon, Aubry K. Miller & Tobias P. Dick Nat. Chem. ( 2025 ). [link] Proton pump inhibitors have become top-selling drugs worldwide. Serendipitously discovered as prodrugs that are activated by protonation in acidic environments, proton pump inhibitors inhibit stomach acid secretion by cov
BioPharma Drive: Drug Pricing
FEBRUARY 21, 2025
The pioneering gene therapy developer will be acquired by investment firms Carlyle Group and SK Capital for a fraction of what it was once worth years ago.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Drugs.com
FEBRUARY 20, 2025
THURSDAY, Feb. 20, 2025 -- Two indoor cats in Oregon were euthanized after contracting bird flu, leading to a recall of raw pet food sold in both Oregon and Washington, health officials have announced. The cats were from separate households and had.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Collaborative Drug
FEBRUARY 21, 2025
CDD Update February 2025 #2 New Macromolecule Mode Edit DNA, RNA & Peptides with Bioconjugate Support
BioPharma Drive: Drug Pricing
FEBRUARY 20, 2025
The $160 million acquisition of a FibroGen subsidiary expands AstraZeneca’s foothold in China while the company works through government investigations into its business practices there.
Drugs.com
FEBRUARY 21, 2025
FRIDAY, Feb. 21, 2025 -- The health benefits of aggressive blood pressure control outweigh the potential risks for seniors, according to the latest results from a major clinical trial.About 85% of seniors treated to a target blood pressure of 120.
Science Daily: Pharmacology News
FEBRUARY 20, 2025
Large birds -- our closest relations to dinosaurs -- are capable of technical innovation, by solving a physical task to gain access to food.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Alta Sciences
FEBRUARY 19, 2025
Regulatory Guidance for Oligonucleotide Bioanalysis in Drug Development pmjackson Wed, 02/19/2025 - 21:30 The unique physicochemical properties of oligonucleotides require the use of specialized bioanalytical approaches, with key considerations including selectivity and specificity, sensitivity, stability, and matrix effects. Addressing these factors means bioanalytical methods can effectively differentiate oligonucleotides from endogenous nucleic acids and metabolites, quantify low concentratio
BioPharma Drive: Drug Pricing
FEBRUARY 20, 2025
"Any place that gets cut, it's going to have an impact, because there's not any spare personnel at FDA,” said former agency commissioner Robert Califf.
Drugs.com
FEBRUARY 18, 2025
TUESDAY, Feb. 18, 2025 -- The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active immunization against invasive meningococcal disease (IMD), according to a press release from.
Science Daily: Pharmacology News
FEBRUARY 21, 2025
Researchers are blurring the lines between robotics and materials, with a proof-of-concept material-like collective of robots with behaviors inspired by biology.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
SugarCone Biotech
FEBRUARY 16, 2025
There were waves of interest in this therapeutic space at ASCO in June 2024 and around the JP Morgan healthcare conference in January 2025. Here we take a look at the hope and the hype behind the PD1/VEGF bispecific therapeutics.
BioPharma Drive: Drug Pricing
FEBRUARY 21, 2025
The FDA determined that Novo Nordisk’s obesity and diabetes drugs are no longer in short supply. Elsewhere, Concentra made a competing bid for Acelyrin and Intra-Cellular sales rose.
Drugs.com
FEBRUARY 16, 2025
SUNDAY, Feb. 16, 2025 -- Flu season is in full swing, making it more important than ever to take steps to protect yourself and your loved ones.Dr. Priya Soni, a pediatric infectious disease specialist at Cedars-Sinai Guerin Childrens Health Center.
Science Daily: Pharmacology News
FEBRUARY 20, 2025
Fetal acetaminophen exposure increases the likelihood that a child will develop attention-deficit/hyperactivity disorder (ADHD), according to a new study.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Fierce BioTech
FEBRUARY 20, 2025
In a recent interview with Fierce Biotech's Chris Hayden, Fortrea's Chief Technology and Data Officer Alaric Jackson discussed the growing role of AI in clinical trials. | Fortrea's CTO discusses AI's expanding role in clinical trials, from discovery to execution, and its potential to improve patient outcomes and diversity.
BioPharma Drive: Drug Pricing
FEBRUARY 19, 2025
Scott Whitaker sent a letter to HHS calling for staff cuts at the FDA to be reversed, arguing patient care and U.S. leadership in medical devices are on the line.
Drugs.com
FEBRUARY 20, 2025
THURSDAY, Feb. 20, 2025 -- The societal stress and stigma of being LGBTQ+ can increase a persons risk of mental health problems, a new study suggests.People in sexual and gender minorities are more likely than heterosexuals to suffer from problems.
Science Daily: Pharmacology News
FEBRUARY 20, 2025
Narcissists feel ostracized more frequently than their less self-absorbed peers, according to researchers. This may stem not only from being shunned due to their personalities but from a tendency to misinterpret ambiguous social signals as exclusion.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Fierce BioTech
FEBRUARY 19, 2025
| Avoid common pitfalls in EU orphan drug market accesslearn how local expertise can help navigate pricing, reimbursement, and regulatory hurdles.
BioPharma Drive: Drug Pricing
FEBRUARY 21, 2025
Pfizer’s decision to halt further marketing of Beqvez is further sign of the sparse patient interest in gene therapies for the bleeding condition.
Drugs.com
FEBRUARY 18, 2025
TUESDAY, Feb. 18, 2025 -- The U.S. Department of Agriculture (USDA) has granted conditional approval for a new bird flu vaccine for poultry.This new avian flu vaccine, developed by New Jersey-based Zoetis, was approved last week after meeting.
Science Daily: Pharmacology News
FEBRUARY 17, 2025
Bringing aromas indoors with the help of chemical products -- yes, air fresheners, wax melts, floor cleaners, deodorants and others -- rapidly fills the air with nanoscale particles that are small enough to get deep into your lungs, engineers have found over a series of studies.
Metabolite Tales Blog
FEBRUARY 20, 2025
Welcome to Matt and Xianfu We are delighted thatMatthew AllenandXianfu Li have joined Hypha’s team recently. Xianfu was previously at Evotec and specialises in metabolite identification and bioanalysis. Matt joins us from Charnwood Molecular and is Hypha’s Chemistry Lab Manager. The post Welcome to Matt and Xianfu appeared first on Hypha Discovery.
BioPharma Drive: Drug Pricing
FEBRUARY 19, 2025
Chris Gibson, Recursion’s head, cited the role small business grants played in helping his company grow its business.
Drugs.com
FEBRUARY 21, 2025
FRIDAY, Feb. 21, 2025 -- One of the NBA's most exciting rising stars will spend the rest of the 2024-2025 season on the bench. Victor Wembanyama, the San Antonio Spurs' 7-foot 3-inch phenom, was sidelined after doctors discovered a dangerous blood.
Science Daily: Pharmacology News
FEBRUARY 20, 2025
A little movement could help prevent dementia, even for frail older adults, suggests a new study.
Expert insights. Personalized for you.
254 
Let's personalize your content